Medistim ASA (LON:0OCD)

Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of GBP 335.45 million. The enterprise value is 329.89 million.

Market Cap	335.45M
Enterprise Value	329.89M

Important Dates

The last earnings date was Wednesday, August 20, 2025.

Earnings Date	Aug 20, 2025
Ex-Dividend Date	May 9, 2025

Share Statistics

Current Share Class	18.27M
Shares Outstanding	n/a
Shares Change (YoY)	-0.07%
Shares Change (QoQ)	-0.33%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	12.61M

Valuation Ratios

The trailing PE ratio is 35.45 and the forward PE ratio is 30.51.

PE Ratio	35.45
Forward PE	30.51
PS Ratio	7.40
PB Ratio	12.11
P/TBV Ratio	14.67
P/FCF Ratio	31.82
P/OCF Ratio	30.55
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.74, with an EV/FCF ratio of 31.29.

EV / Earnings	34.86
EV / Sales	7.01
EV / EBITDA	22.74
EV / EBIT	25.74
EV / FCF	31.29

Financial Position

The company has a current ratio of 3.14, with a Debt / Equity ratio of 0.06.

Current Ratio	3.14
Quick Ratio	1.73
Debt / Equity	0.06
Debt / EBITDA	0.11
Debt / FCF	0.15
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 34.19% and return on invested capital (ROIC) is 26.75%.

Return on Equity (ROE)	34.19%
Return on Assets (ROA)	21.13%
Return on Invested Capital (ROIC)	26.75%
Return on Capital Employed (ROCE)	41.59%
Revenue Per Employee	294,265
Profits Per Employee	61,441
Employee Count	154
Asset Turnover	1.24
Inventory Turnover	0.71

Taxes

In the past 12 months, Medistim ASA has paid 2.95 million in taxes.

Income Tax	2.95M
Effective Tax Rate	23.75%

Stock Price Statistics

The stock price has increased by +39.99% in the last 52 weeks. The beta is 0.76, so Medistim ASA's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	+39.99%
50-Day Moving Average	228.89
200-Day Moving Average	199.24
Relative Strength Index (RSI)	50.31
Average Volume (20 Days)	194

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of GBP 45.32 million and earned 9.46 million in profits. Earnings per share was 0.52.

Revenue	45.32M
Gross Profit	36.59M
Operating Income	12.34M
Pretax Income	12.41M
Net Income	9.46M
EBITDA	13.33M
EBIT	12.34M
Earnings Per Share (EPS)	0.52

Balance Sheet

The company has 6.95 million in cash and 1.59 million in debt, giving a net cash position of 5.36 million.

Cash & Cash Equivalents	6.95M
Total Debt	1.59M
Net Cash	5.36M
Net Cash Per Share	n/a
Equity (Book Value)	27.69M
Book Value Per Share	1.52
Working Capital	19.07M

Cash Flow

In the last 12 months, operating cash flow was 10.98 million and capital expenditures -437,812, giving a free cash flow of 10.54 million.

Operating Cash Flow	10.98M
Capital Expenditures	-437,812
Free Cash Flow	10.54M
FCF Per Share	n/a

Margins

Gross margin is 80.74%, with operating and profit margins of 27.23% and 20.88%.

Gross Margin	80.74%
Operating Margin	27.23%
Pretax Margin	27.38%
Profit Margin	20.88%
EBITDA Margin	29.42%
EBIT Margin	27.23%
FCF Margin	23.26%

Dividends & Yields

This stock pays an annual dividend of 0.44, which amounts to a dividend yield of 0.18%.

Dividend Per Share	0.44
Dividend Yield	0.18%
Dividend Growth (YoY)	32.83%
Years of Dividend Growth	n/a
Payout Ratio	83.79%
Buyback Yield	0.07%
Shareholder Yield	0.25%
Earnings Yield	2.82%
FCF Yield	3.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6